*Prague Psychiatric Center, 3rd Faculty of Medicine, Charles University, Center of Neuro psychiatric Studies, Prague, Czech Republic
†Czech Technical University, Faculty of Electrical Engineering, Department of Cybernetics, Prague.
Filip Španiel MD, Tomáš Novák MD, Jiří Kožený, PsyD, Cyril Höschl, MD, Pavel Mohr, MD, and Lucie Bankovská Motlová, MD, received honoraria from Eli Lilly Co. Jan Hrdlička, MA, declares no conflicts of interest.
Acknowledgement: This was an investigator-initiated trial funded by Eli Lilly Company. Eli Lilly had no further role in the collection, analysis, and interpretation of data. ITAREPS was developed by the Prague Psychiatric Centre as an academic project, technically supported by Academia Medica Pragensis (Amepra). Amepra is an agent and ethical guarantor of relations between Eli Lilly Czech Republic which provided funds for ITAREPS development and the academic group involved in the project development and implementation. ITAREPS (http://www.itareps.com) is operated under the auspices of the Psychiatric Society CLS JEP of the Czech Republic and the Psychiatric Society SLS of the Slovak Republic. We greatly appreciate the consultation and invaluable help in study design of Drs. R. Brousil and P. Vohlídka.
Please send correspondence to: Filip Španiel, MD, Prague Psychiatric Center, Ústavní 191, 181 03 Prague 8, Czech Republic. [email protected]
